Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Application of membrane-active peptides for nonviral gene delivery

Identifieur interne : 002623 ( Main/Exploration ); précédent : 002622; suivant : 002624

Application of membrane-active peptides for nonviral gene delivery

Auteurs : Ernst Wagner [Autriche]

Source :

RBID : ISTEX:69A4F2E2D5B914D56FDBD0AA505EECFB6AFE8AF2

English descriptors

Abstract

Abstract: A variety of membrane-modifying agents including pH-specific fusogenic or lytic peptides, bacterial proteins, lipids, glycerol, or inactivated virus particles have been evaluated for the enhancement of DNA–polycation complex-based gene transfer. The enhancement depends on the characteristics of both the cationic carrier for DNA and the membrane-modifying agent. Peptides derived from viral sequences such as the N-terminus of influenza virus haemagglutinin HA-2, the N-terminus of rhinovirus HRV2 VP-1 protein, and other synthetic or natural sequences such as the amphipathic peptides GALA, KALA, EGLA, JTS1, or gramicidin S have been tested. Ligand–polylysine-mediated gene transfer can be improved up to more than 1000-fold by membrane-active compounds. Other polycations like dendrimers or polyethylenimines as well as several cationic lipids provide a high transfection efficiency per se. Systems based on these polymers or lipids are only slightly enhanced by endosomolytic peptides or adenoviruses. Electroneutral cationic lipid–DNA complexes however can be strongly improved by the addition of membrane-active peptides.

Url:
DOI: 10.1016/S0169-409X(99)00033-2


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Application of membrane-active peptides for nonviral gene delivery</title>
<author>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:69A4F2E2D5B914D56FDBD0AA505EECFB6AFE8AF2</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0169-409X(99)00033-2</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-GMXC5TN3-N/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002B09</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002B09</idno>
<idno type="wicri:Area/Istex/Curation">002B09</idno>
<idno type="wicri:Area/Istex/Checkpoint">001439</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001439</idno>
<idno type="wicri:doubleKey">0169-409X:1999:Wagner E:application:of:membrane</idno>
<idno type="wicri:Area/Main/Merge">002659</idno>
<idno type="wicri:Area/Main/Curation">002623</idno>
<idno type="wicri:Area/Main/Exploration">002623</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Application of membrane-active peptides for nonviral gene delivery</title>
<author>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Biochemistry, Vienna University Biocenter, Dr. Bohrgasse 9/3, A-1030 Vienna</wicri:regionArea>
<wicri:noRegion>A-1030 Vienna</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Advanced Drug Delivery Reviews</title>
<title level="j" type="abbrev">ADR</title>
<idno type="ISSN">0169-409X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1999">1999</date>
<biblScope unit="volume">38</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="279">279</biblScope>
<biblScope unit="page" to="289">289</biblScope>
</imprint>
<idno type="ISSN">0169-409X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0169-409X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acad</term>
<term>Acta</term>
<term>Adenovirus</term>
<term>Adenovirus particles</term>
<term>Amphipathic</term>
<term>Amphipathic peptides</term>
<term>Biochem</term>
<term>Biochemistry</term>
<term>Biochim</term>
<term>Biol</term>
<term>Biophys</term>
<term>Birnstiel</term>
<term>Cationic</term>
<term>Cationic lipids</term>
<term>Cationic liposomes</term>
<term>Chem</term>
<term>Diphtheria toxin</term>
<term>Drug delivery reviews</term>
<term>Endocytosis</term>
<term>Endosomal</term>
<term>Endosomal membrane</term>
<term>Endosomal release</term>
<term>Endosome</term>
<term>Gene</term>
<term>Gene delivery</term>
<term>Gene expression</term>
<term>Gene therapy</term>
<term>Gene transfer</term>
<term>Intracellular</term>
<term>Ligand</term>
<term>Lipid</term>
<term>Lipofection</term>
<term>Liposome</term>
<term>Mammalian cells</term>
<term>Mechtler</term>
<term>Membrane</term>
<term>Membrane barriers</term>
<term>Membrane fusion</term>
<term>Natl</term>
<term>Nonviral</term>
<term>Nucleic</term>
<term>Nucleic acids</term>
<term>Other polycations</term>
<term>Pathway</term>
<term>Peptide</term>
<term>Peptide sequence</term>
<term>Polyfection</term>
<term>Polylysine</term>
<term>Polymer</term>
<term>Proc</term>
<term>Receptor</term>
<term>Synthetic peptides</term>
<term>Szoka</term>
<term>Toxin</term>
<term>Transfection</term>
<term>Transfection activity</term>
<term>Vesicle</term>
<term>Viral</term>
<term>Vivo gene transfer</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: A variety of membrane-modifying agents including pH-specific fusogenic or lytic peptides, bacterial proteins, lipids, glycerol, or inactivated virus particles have been evaluated for the enhancement of DNA–polycation complex-based gene transfer. The enhancement depends on the characteristics of both the cationic carrier for DNA and the membrane-modifying agent. Peptides derived from viral sequences such as the N-terminus of influenza virus haemagglutinin HA-2, the N-terminus of rhinovirus HRV2 VP-1 protein, and other synthetic or natural sequences such as the amphipathic peptides GALA, KALA, EGLA, JTS1, or gramicidin S have been tested. Ligand–polylysine-mediated gene transfer can be improved up to more than 1000-fold by membrane-active compounds. Other polycations like dendrimers or polyethylenimines as well as several cationic lipids provide a high transfection efficiency per se. Systems based on these polymers or lipids are only slightly enhanced by endosomolytic peptides or adenoviruses. Electroneutral cationic lipid–DNA complexes however can be strongly improved by the addition of membrane-active peptides.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Autriche</li>
</country>
</list>
<tree>
<country name="Autriche">
<noRegion>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002623 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002623 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:69A4F2E2D5B914D56FDBD0AA505EECFB6AFE8AF2
   |texte=   Application of membrane-active peptides for nonviral gene delivery
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021